1-(TERT-BUTOXYCARBONYL)-4-(3-CHLOROPHENYL)PIPERIDINE-4-CARBOXYLIC ACID, 95.0%, 5g

Benceno, mínimo 99,5 %, ultrapuro, 1 l, envase de vidrio

4-Bromo-2-methylbenzo[d]thiazole, 95.0%, 1g

(3aR,8aR)-2,2-Dimethyl-4,4,6,8,8-pentaphenyltetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine, 97%, 1g

2,6-Dichloro-9-(tetrahydro-2H-pyran-2-yl)-9H-purine, 95.0%, 100mg

7-Bromoimidazo[1,5-a]pyridine, 95.0%, 250mg

N-a-Boc-N-e-allyloxycarbonyl-L-lysine dicyclohexylaminesalt, 95.0%, 5g

TERT-BUTYL (2S,4S)-4-HYDROXY-2-(METHOXYMETHYL)PYRROLIDINE-1-CARBOXYLATE, 95.0%, 1g

Ethyl 2-(5-bromo-2-methyl-1H-indol-3-yl)acetate, 96%, 1g

3-Bromo-5-cyanopyridine, 98.0%, 100g

6,6-Difluoro-1,4-diazepane dihydrochloride, 95+%, 1g

Isonicotinimidamide hydrochloride, 97.0%, 100g

4-Bromo-2-fluoro-5-methylpyridine, 95.0%, 25g